Hussain M - Search Results

1

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.

Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Cooney MM, Garcia JA, DiPaola RS, Sweeney CJ. Kyriakopoulos CE, et al. Among authors: hussain m. J Clin Oncol. 2018 Apr 10;36(11):1080-1087. doi: 10.1200/JCO.2017.75.3657. Epub 2018 Jan 31. J Clin Oncol. 2018. PMID: 29384722 Free PMC article. Clinical Trial.

2

Oral etoposide in the treatment of hormone-refractory prostate cancer.

Hussain MH, Pienta KJ, Redman BG, Cummings GD, Flaherty LE. Hussain MH, et al. Cancer. 1994 Jul 1;74(1):100-3. doi: 10.1002/1097-0142(19940701)74:1<100::aid-cncr2820740118>3.0.co;2-k. Cancer. 1994. PMID: 8004566

3

Future directions in prostate cancer treatment: an oncologist's perspective.

Hussain M. Hussain M. Prostate Suppl. 1996;6:26-30. Prostate Suppl. 1996. PMID: 8630225 Review.

4

Southwest Oncology Group studies in hormone-refractory prostate cancer.

Hussain MH, Blumenstein B, Eisenberger M, Crawford ED. Hussain MH, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):24-7. Semin Oncol. 1996. PMID: 8996581 Review.

5

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).

Pienta KJ, Fisher EI, Eisenberger MA, Mills GM, Goodwin JW, Jones JA, Dakhil SR, Crawford ED, Hussain MH. Pienta KJ, et al. Among authors: hussain mh. Prostate. 2001 Mar 1;46(4):257-61. doi: 10.1002/1097-0045(20010301)46:4<257::aid-pros1031>3.0.co;2-4. Prostate. 2001. PMID: 11241547 Free article. Clinical Trial.

6

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).

Kucuk O, Fisher E, Moinpour CM, Coleman D, Hussain MH, Sartor AO, Chatta GS, Lowe BA, Eisenberger MA, Crawford ED. Kucuk O, et al. Among authors: hussain mh. Urology. 2001 Jul;58(1):53-8. doi: 10.1016/s0090-4295(01)01010-x. Urology. 2001. PMID: 11445479 Clinical Trial.

7

Ten-year survival in patients with metastatic prostate cancer.

Tangen CM, Faulkner JR, Crawford ED, Thompson IM, Hirano D, Eisenberger M, Hussain M. Tangen CM, et al. Among authors: hussain m. Clin Prostate Cancer. 2003 Jun;2(1):41-5. doi: 10.3816/cgc.2003.n.011. Clin Prostate Cancer. 2003. PMID: 15046683 Clinical Trial.

8

Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma.

Vaishampayan U, Fontana J, Du W, Hussain M. Vaishampayan U, et al. Among authors: hussain m. Am J Clin Oncol. 2004 Dec;27(6):550-4. doi: 10.1097/01.coc.0000135922.12198.e4. Am J Clin Oncol. 2004. PMID: 15577431 Clinical Trial.

9

Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomes.

Macvicar GR, Hussain M. Macvicar GR, et al. Among authors: hussain m. Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:69-77. doi: 10.1007/s00280-005-0103-7. Cancer Chemother Pharmacol. 2005. PMID: 16273364 Free article. Review.

10

Should intermittent androgen deprivation be used in routine clinical practice?

Bhandari MS, Crook J, Hussain M. Bhandari MS, et al. Among authors: hussain m. J Clin Oncol. 2005 Nov 10;23(32):8212-8. doi: 10.1200/JCO.2005.03.2557. J Clin Oncol. 2005. PMID: 16278475 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,153 results

Search Page